Compound Info
NAs Base Info
ID Cluster Name Target MolWt
Compound Structure
NAs.008389 2
Target name Tax id
Nicotinamide N-methyltransferase
Phenylethanolamine N-methyltransferase
Histone-lysine N-methyltransferase
H3 lysine-9 specific 5
DNA (cytosine-5)-methyltransferase 3A
Protein-arginine N-methyltransferase 1
Histone-lysine N-methyltransferase SETDB1
Guanidinoacetate N-methyltransferase
Histamine N-methyltransferase
Histone-lysine N-methyltransferase
H3 lysine-79 specific
Histone-lysine N-methyltransferase
H3 lysine-9 specific 3
Glycine N-methyltransferase
Histone-lysine N-methyltransferase ASH1L
Catechol O-methyltransferase
Indolethylamine N-methyltransferase
Thiopurine S-methyltransferase
509.523
Chemical Representations
InChI InChI=1S/C24H27N7O6/c25-15(24(35)36)7-6-13(5-4-12-2-1-3-14(8-12)21(27)34)9-16-18(32)19(33)23(37-16)31-11-30-17-20(26)28-10-29-22(17)31/h1-3,8,10-11,13,15-16,18-19,23,32-33H,6-7,9,25H2,(H2,27,34)(H,35,36)(H2,26,28,29)/t13-,15-,16+,18+,19+,23+/m0/s1
InChI Key QRKSTGPKAQGBDD-GGPTZFPQSA-N
SMILES NC(=O)c1cccc(C#C[C@@H](CC[C@H](N)C(=O)O)C[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)c1
Molecular Formula C24H27N7O6
Functional Fragments
Base Ribose Phosphate
Base Structure
Match
No Image Available
Match
Calculated Properties
logP -0.623 Computed by RDKit
Heavy Atom Count 37 Computed by RDKit
Ring Count 4 Computed by RDKit
Hydrogen Bond Acceptor Count 11 Computed by RDKit
Hydrogen Bond Donor Count 6 Computed by RDKit
Rotatable Bond Count 8 Computed by RDKit
Topological Polar Surface Area 225.720 Computed by RDKit
Activity Data
Target Activity type Relation Value Unit Assay Source
Nicotinamide N-methyltransferase Ki = 0.5 nM Inhibition of N-terminal His6-tagged wild type human NNMT expressed in Escherichia coli NiCo21(DE3) assessed as reduction in 1-methylquinolinium level using quinoline as substrate in presence of SAM and measured every 27 seconds for 5.5 mins by fluorescence-based assay CHEMBL4414609
Nicotinamide N-methyltransferase Ki = 0.5012 nM Inhibition of N-terminal His6-tagged wild type human NNMT expressed in Escherichia coli NiCo21(DE3) assessed as reduction in 1-methylquinolinium level using quinoline as substrate in presence of SAM and measured every 27 seconds for 5.5 mins by fluorescence-based assay CHEMBL4414609
Thiopurine S-methyltransferase Inhibition = 76.0 % Inhibition of human TPMT expressed in Escherichia coli assessed as reduction in SAH level at 10 uM using 6-mercaptopurine as substrate in presence of SAM incubated for 30 mins by LC-MS/MS analysis relative to control CHEMBL4414609
Indolethylamine N-methyltransferase Inhibition = 53.0 % Inhibition of wild type human INMT expressed in Escherichia coli at 10 uM using tryptamine as substrate in presence of SAM incubated for 30 mins by MTase-Glo assay relative to control CHEMBL4414609
Catechol O-methyltransferase Inhibition = 43.0 % Inhibition of human COMT expressed in Escherichia coli at 10 uM assessed as reduction in SAH level using pyrocatechol as substrate in presence of SAM incubated for 15 mins by LC-MS/MS analysis relative to control CHEMBL4414609
Phenylethanolamine N-methyltransferase Inhibition = 26.0 % Inhibition of human PNMT expressed in Escherichia coli at 10 uM assessed as reduction in SAH level using DL-normetanephrine as substrate in presence of SAM incubated for 45 mins by LC-MS/MS analysis relative to control CHEMBL4414609
Guanidinoacetate N-methyltransferase Inhibition = 26.0 % Inhibition of human GAMT expressed in Escherichia coli at 10 uM assessed as reduction in SAH level using guanidineacetic acid as substrate in presence of SAM incubated for 30 mins by LC-MS/MS analysis relative to control CHEMBL4414609
Glycine N-methyltransferase Inhibition = 23.0 % Inhibition of human GNMT expressed in Escherichia coli at 10 uM assessed as reduction in SAH level using glycine as substrate in presence of SAM incubated for 30 mins by LC-MS/MS analysis relative to control CHEMBL4414609
Histamine N-methyltransferase Inhibition = 2.0 % Inhibition of human HNMT expressed in Escherichia coli at 10 uM assessed as reduction in SAH level using histamine as substrate in presence of SAM incubated for 15 mins by LC-MS/MS analysis relative to control CHEMBL4414609
Thiopurine S-methyltransferase Inhibition = 51.0 % Inhibition of human TPMT expressed in Escherichia coli assessed as reduction in SAH level at 1 uM using 6-mercaptopurine as substrate in presence of SAM incubated for 30 mins by LC-MS/MS analysis relative to control CHEMBL4414609
Indolethylamine N-methyltransferase Inhibition = 14.0 % Inhibition of wild type human INMT expressed in Escherichia coli at 1 uM using tryptamine as substrate in presence of SAM incubated for 30 mins by MTase-Glo assay relative to control CHEMBL4414609
Catechol O-methyltransferase Inhibition = 0.0 % Inhibition of human COMT expressed in Escherichia coli at 1 uM assessed as reduction in SAH level using pyrocatechol as substrate in presence of SAM incubated for 15 mins by LC-MS/MS analysis relative to control CHEMBL4414609
Phenylethanolamine N-methyltransferase Inhibition = 0.0 % Inhibition of human PNMT expressed in Escherichia coli at 1 uM assessed as reduction in SAH level using DL-normetanephrine as substrate in presence of SAM incubated for 45 mins by LC-MS/MS analysis relative to control CHEMBL4414609
Guanidinoacetate N-methyltransferase Inhibition = 0.0 % Inhibition of human GAMT expressed in Escherichia coli at 1 uM assessed as reduction in SAH level using guanidineacetic acid as substrate in presence of SAM incubated for 30 mins by LC-MS/MS analysis relative to control CHEMBL4414609
Glycine N-methyltransferase Inhibition = 4.0 % Inhibition of human GNMT expressed in Escherichia coli at 1 uM assessed as reduction in SAH level using glycine as substrate in presence of SAM incubated for 30 mins by LC-MS/MS analysis relative to control CHEMBL4414609
Histamine N-methyltransferase Inhibition = 6.0 % Inhibition of human HNMT expressed in Escherichia coli at 1 uM assessed as reduction in SAH level using histamine as substrate in presence of SAM incubated for 15 mins by LC-MS/MS analysis relative to control CHEMBL4414609
DNA (cytosine-5)-methyltransferase 3A IC50 = 7600.0 nM Inhibition of human DNMT3a expressed in insect sf9 cells assessed as reduction in methylated poly(dI-dC)-Poly(dI-dC) level using poly(dI-dC)-poly(dI-dC) as substrate in presence of [3H] SAM incubated for 10 mins by scintillation counting CHEMBL4414609
Protein-arginine N-methyltransferase 1 IC50 > 10000.0 nM Inhibition of human PRMT1 expressed in Escherichia coli assessed as reduction in methylated histone H4 full length level using histone H4 full length as substrate in presence of [3H] SAM incubated for 20 mins by scintillation counting CHEMBL4414609
Histone-lysine N-methyltransferase ASH1L IC50 > 10000.0 nM Inhibition of human ASH1L expressed in Escherichia coli assessed as reduction in methylated polynucleosome level using polynucleosome as substrate in presence of [3H] SAM incubated for 15 mins by scintillation counting CHEMBL4414609
Histone-lysine N-methyltransferase, H3 lysine-79 specific IC50 > 10000.0 nM Inhibition of human DOT1L expressed in Escherichia coli assessed as reduction in methylated polynucleosome level using polynucleosome as substrate in presence of [3H] SAM incubated for 15 mins by scintillation counting CHEMBL4414609
Histone-lysine N-methyltransferase, H3 lysine-9 specific 5 IC50 > 10000.0 nM Inhibition of human EHMT1 expressed in Escherichia coli assessed as reduction in methylated histone H3 full length using histone H3 full length as substrate in presence of [3H] SAM incubated for 120 mins by scintillation counting CHEMBL4414609
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 IC50 > 10000.0 nM Inhibition of human G9a expressed in Escherichia coli assessed as reduction in methylated histone H3 full length using histone H3 full length level as substrate in presence of [3H] SAM incubated for 120 mins by scintillation counting CHEMBL4414609
Histone-lysine N-methyltransferase SETDB1 IC50 > 10000.0 nM Inhibition of human SETDB1 expressed in sf9 insect cells assessed as reduction in methylated histone H3 full length level using histone H3 full length as substrate in presence of [3H] SAM incubated for 30 mins by scintillation counting CHEMBL4414609
Thiopurine S-methyltransferase IC50 = 1000.0 nM Inhibition of human TPMT expressed in Escherichia coli assessed as reduction in SAH level using 6-mercaptopurine as substrate in presence of SAM incubated for 30 mins by LC-MS/MS analysis CHEMBL4414609
Indolethylamine N-methyltransferase IC50 = 3400.0 nM Inhibition of wild type human INMT expressed in Escherichia coli using tryptamine as substrate in presence of SAM incubated for 30 mins by MTase-Glo assay CHEMBL4414609
Nicotinamide N-methyltransferase Delta Tm = 8.0 degrees C Binding affinity to NNMT in human K562 cell lysates assessed as change in melting temperature at 100 uM incubated for 30 mins by CETSA-based Western blot analysis CHEMBL4414609
Nicotinamide N-methyltransferase Activity Binding affinity to NNMT in human K562 cell lysates incubated for 30 mins by CETSA-based Western blot analysis CHEMBL4414609
U2OS Activity Cytotoxicity against human U2OS cells at 100 uM after 48 hrs by CellTiter-Glo luminescent cell viability CHEMBL4414609
Nicotinamide N-methyltransferase Inhibition % Inhibition of NNMT in human U2OS cells assessed as reduction in MNAM level incubated for 24 hrs by LC-MS/MS analysis CHEMBL4414609
ADMET permeability Permeability across apical to basolateral side in human Caco2 cells after 60 mins by HPLC-MS/MS analysis CHEMBL4414609